AB Corporate Bond ETF (NASDAQ:EYEG) Plans Monthly Dividend of $0.13

AB Corporate Bond ETF (NASDAQ:EYEG) announced a monthly dividend on Monday, August 31st. Stockholders of record on Tuesday, September 1st will be paid a dividend of 0.1284 per share by the specialty pharmaceutical company on Friday, September 4th. This represents a c) dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date is Tuesday, September 1st.

AB Corporate Bond ETF Stock Down 0.1%

EYEG stock opened at $34.58 on Tuesday. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.07 and a quick ratio of 3.07. The stock has a market capitalization of $27.66 million, a P/E ratio of -20.58 and a beta of 0.18. AB Corporate Bond ETF has a fifty-two week low of $34.46 and a fifty-two week high of $36.63. The business has a 50-day moving average of $34.80 and a 200-day moving average of $35.18.

Institutional Trading of AB Corporate Bond ETF

An institutional investor recently bought a new stake in AB Corporate Bond ETF stock. Kestra Advisory Services LLC bought a new position in shares of AB Corporate Bond ETF (NASDAQ:EYEG) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 951 shares of the specialty pharmaceutical company’s stock, valued at approximately $34,000. Kestra Advisory Services LLC owned about 0.13% of AB Corporate Bond ETF at the end of the most recent quarter. 64.16% of the stock is currently owned by institutional investors and hedge funds.

About AB Corporate Bond ETF

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.